Ipamorelin research peptide procurement brief: GHS-R1a secretagogue documentation

This procurement brief helps laboratory purchasing and QA teams evaluate Ipamorelin as research-use-only material: what identity fields to confirm, what a valid lot CoA must include, how to handle receiving, and which documentation red flags should stop inventory acceptance. It is not medical, dosing, or consumer guidance.

Identity fields to confirm before accepting the lot

Ipamorelin is a short GHS-R1a pentapeptide. Confirm sequence and MW (~712 Da class) on the CoA; do not accept a CJC-1295 CoA as a proxy.

Match SKU, lot number, and CoA document ID before opening the outer carton. Photograph labels when your chain-of-custody SOP requires it.

What a valid CoA must show

Lot-specific HPLC purity, MS identity, and net peptide content. Parallel stocking with CJC-1295 is common for study design—not because they are substitutes.

Prefer suppliers that also allow public lot verification. BluGen lots can be checked in the CoA Library when published for that batch.

reconstitution-and-concentration-math">Storage, reconstitution, and concentration math

Generally more handling-robust than long GHRH analogues, but still requires cold lyophilized storage and freeze–thaw discipline after reconstitution.

Use net peptide content for molarity calculations. Gross vial mass systematically overstates active peptide when water and counter-ions are present.

Documentation red flags

Any of the following should trigger quarantine pending supplier clarification:

• Protocol substitution with GHRH analogues
• Missing MS identity on short peptides (still required)
• Unlabeled vials in multi-secretagogue orders

Next steps

Open the Ipamorelin product page for SKU variants and identity tables, then read the matching research guide and any related comparison article before finalizing the PO.

Pair this brief with the supplier evaluation checklist, CoA reading guide, and reconstitution calculator for a complete receiving package.